BIAFNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAFW
bioAffinity Technologies, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.51−0.22 (-5.90%)
Close on Oct 19, 2026
- Market cap
- $18.35M
- P/E (TTM)
- –
- Dividend yield
- –
bioAffinity Technologies, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory Services [Member] | $1.51M | $1.35M | $1.59M | $1.45M | $1.27M | $1.85M | $2.21M | $2.35M | $2.39M | $2.40M | $2.21M | $284.23K | 100.0% | +19.0% |
| Health Care, Patient Service [Member] | $1.24M | $1.08M | $1.29M | $1.17M | $942.07K | $1.57M | $1.92M | $2.05M | $2.06M | $2.15M | $1.95M | – | 82.4% | +32.1% |
| Histology Service Fees [Member] | $248.26K | $250.52K | $288.97K | $255.59K | $308.60K | $263.75K | $291.84K | $281.86K | $292.08K | $237.97K | $240.81K | – | 16.4% | -19.6% |
| Medical Director Fees [Member] | $17.54K | $17.46K | $17.10K | $17.27K | $17.31K | $16.59K | $16.44K | $16.94K | $17.14K | $16.06K | – | – | 1.2% | +1.4% |
| Other Revenues [Member] | $633 | $209 | $226 | $258 | $1.50K | $2.87K | – | $0 | $23.49K | $427 | – | $1.33K | 0.0% | -57.9% |
| Diagnostic R&D [Member] | $0 | $1.13K | – | – | – | – | $0 | $1.73K | $4.04K | $2.89K | $5.19K | $14.25K | 0.0% | – |
| Department of Defense Observational Studies [Member] | $0 | $1.13K | – | – | – | – | $0 | $1.73K | $4.04K | $2.89K | $5.19K | – | 0.0% | – |
| Royalty Income [Member] | – | – | – | – | – | – | – | – | – | – | – | $5.41K | – | – |
| Defense Study [Member] | – | – | – | – | – | – | – | – | – | – | – | $4.50K | – | – |
| Health Care, Other [Member] | – | – | – | – | – | – | – | $16.94K | $17.14K | $16.06K | $16.93K | – | – | – |
| Department Of Defense Observational Studiesr [Member] | – | – | – | – | – | – | – | – | – | $2.89K | – | – | – | – |
| Histology Fees [Member] | – | – | – | – | – | – | – | – | – | $237.97K | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of bioAffinity Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.